ARCT - Arcturus Therapeutics EPS misses by $0.33 misses on revenue March, 01 2021 04:04 PM Arcturus Therapeutics Ltd. Arcturus Therapeutics (ARCT): Q4 GAAP EPS of -$1.25 misses by $0.33.Revenue of $2.2M (-25.9% Y/Y) misses by $0.12M.Shares +3.7%.Press Release For further details see: Arcturus Therapeutics EPS misses by $0.33, misses on revenue